[go: up one dir, main page]

DK0952151T3 - Mellemprodukter til anvendelse ved fremstilling af nye pyridoncarboxylsyrederivater eller deres salte - Google Patents

Mellemprodukter til anvendelse ved fremstilling af nye pyridoncarboxylsyrederivater eller deres salte

Info

Publication number
DK0952151T3
DK0952151T3 DK99111114T DK99111114T DK0952151T3 DK 0952151 T3 DK0952151 T3 DK 0952151T3 DK 99111114 T DK99111114 T DK 99111114T DK 99111114 T DK99111114 T DK 99111114T DK 0952151 T3 DK0952151 T3 DK 0952151T3
Authority
DK
Denmark
Prior art keywords
halo
salts
intermediates
preparation
acid derivatives
Prior art date
Application number
DK99111114T
Other languages
Danish (da)
English (en)
Inventor
Akira Yazaki
Yoshiko Niino
Yoshihiro Ohshita
Yuzo Wakunaga Hirao
Hirotaka Amano
Norihiro Hayashi
Yasuhiro Kuramoto
Original Assignee
Wakunaga Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26498637&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0952151(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wakunaga Pharma Co Ltd filed Critical Wakunaga Pharma Co Ltd
Application granted granted Critical
Publication of DK0952151T3 publication Critical patent/DK0952151T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Hydrogenated Pyridines (AREA)
  • Quinoline Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK99111114T 1995-09-22 1996-09-20 Mellemprodukter til anvendelse ved fremstilling af nye pyridoncarboxylsyrederivater eller deres salte DK0952151T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26928095 1995-09-22
JP17846296 1996-06-19

Publications (1)

Publication Number Publication Date
DK0952151T3 true DK0952151T3 (da) 2003-09-22

Family

ID=26498637

Family Applications (3)

Application Number Title Priority Date Filing Date
DK99111114T DK0952151T3 (da) 1995-09-22 1996-09-20 Mellemprodukter til anvendelse ved fremstilling af nye pyridoncarboxylsyrederivater eller deres salte
DK99124494T DK0992501T3 (da) 1995-09-22 1996-09-20 Pyridoncarboxylsyre derivater som antibakterielle midler
DK96931264T DK0911327T3 (da) 1995-09-22 1996-09-20 Nye pyridoncarboxylsyrederivater eller deres salte og antibakterielt middel omfattende disse som aktiv bestanddel

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK99124494T DK0992501T3 (da) 1995-09-22 1996-09-20 Pyridoncarboxylsyre derivater som antibakterielle midler
DK96931264T DK0911327T3 (da) 1995-09-22 1996-09-20 Nye pyridoncarboxylsyrederivater eller deres salte og antibakterielt middel omfattende disse som aktiv bestanddel

Country Status (17)

Country Link
US (3) US5998436A (fr)
EP (3) EP0911327B1 (fr)
JP (3) JP3103380B2 (fr)
KR (2) KR100343331B1 (fr)
CN (3) CN1105715C (fr)
AT (3) ATE241601T1 (fr)
AU (1) AU721805B2 (fr)
BR (2) BR9612862B8 (fr)
CA (3) CA2232728C (fr)
DE (3) DE69628466T2 (fr)
DK (3) DK0952151T3 (fr)
ES (3) ES2183473T3 (fr)
HK (2) HK1016602A1 (fr)
HU (3) HU225224B1 (fr)
PT (3) PT952151E (fr)
RU (3) RU2167873C2 (fr)
WO (1) WO1997011068A1 (fr)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0594379U (ja) * 1992-05-11 1993-12-24 株式会社イナックス 便器洗浄水タンクの手洗鉢
WO1999007704A1 (fr) * 1997-08-06 1999-02-18 Suntory Limited Derive de 1-aryl-1,8-naphtylidine-4-one utilise en tant qu'inhibiteur de phosphodiesterase de type iv
JP3477465B2 (ja) * 1999-07-01 2003-12-10 湧永製薬株式会社 キノリンカルボン酸誘導体又はその塩
CA2383759A1 (fr) * 1999-09-02 2001-03-15 Wakunaga Pharmaceutical Co., Ltd. Derive d'acide quinolinecarboxylique ou son sel
JP2005097116A (ja) * 1999-11-11 2005-04-14 Wakunaga Pharmaceut Co Ltd キノリンカルボン酸誘導体アルカリ金属塩及びこれを用いたキノリンカルボン酸誘導体の精製法
JP2005232000A (ja) * 2000-03-10 2005-09-02 Dainippon Pharmaceut Co Ltd ピリドンカルボン酸誘導体又はその塩
ES2292642T3 (es) * 2000-11-20 2008-03-16 Daiichi Sankyo Company, Limited Compuestos deshalogenados.
JP2004535370A (ja) * 2001-03-05 2004-11-25 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 味をマスクした液体製薬学的組成物
WO2003031443A1 (fr) * 2001-10-04 2003-04-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Antibiotiques a action duale renfermant une oxazolidinone et une quinolone ou une fraction de naphthyridinone
US20070155714A1 (en) 2003-04-30 2007-07-05 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections
DE10340485B4 (de) 2003-09-03 2015-05-13 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Verfahren zur Herstellung von Oxazolidinon-Chinolon Hybriden
WO2005026145A2 (fr) * 2003-09-12 2005-03-24 Warner-Lambert Company Llc Agents antibacteriens a base de quinolone
PT1709044E (pt) 2003-12-18 2008-10-27 Morphochem Aktiengese Fur Komb Antibióticos híbridos de oxazolidinona-quinolona
US8158797B2 (en) * 2003-12-18 2012-04-17 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Oxazolidinone-quinolone hybrid antibiotics
US7576216B2 (en) * 2004-07-30 2009-08-18 Abbott Laboratories Preparation of pyridonecarboxylic acid antibacterials
MX2007001134A (es) 2004-07-30 2007-04-17 Abbott Lab Preparacion de antibacterianos de acido piridonacarboxilico.
US20090156577A1 (en) * 2004-09-09 2009-06-18 Benjamin Davis 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
EP1796673A2 (fr) * 2004-09-23 2007-06-20 Reddy US Therapeutics, Inc. Nouveaux composes de pyrimidine, leur procede de preparation, et compositions les contenant
DK3056492T3 (da) * 2004-10-08 2021-12-13 Abbvie Inc Megluminsalt og krystallinke former deraf af et lægemiddel (delafloxacin)
KR20070084159A (ko) * 2004-11-17 2007-08-24 와쿠나가 세이야쿠 가부시키 가이샤 신규 피리돈카르복실산 유도체 또는 그 염
US20080287399A1 (en) * 2004-12-14 2008-11-20 Astrazeneca Ab Substituted Aminopyridines and Uses Thereof
EP1848541A4 (fr) * 2005-02-07 2013-01-16 Pharmalight Inc Procede et dispositif d'administration ophtalmique d'ingredients pharmaceutiquement actifs
RS52354B (en) * 2005-04-11 2012-12-31 Abbott Laboratories PHARMACEUTICAL MIXTURES WHICH HAVE ADVANCED DISSOLUTION PROFILES FOR Slightly Soluble Medicines
JP2009530288A (ja) * 2006-03-16 2009-08-27 ノバルティス アクチエンゲゼルシャフト 特に黒色腫の処置のためのヘテロ環式有機化合物
EP2102165A2 (fr) 2006-11-24 2009-09-23 AC Immune S.A. Derivés n-(méthyl)-1h-pyrazol-3-amine, n-(methyl)-pyridine-2-amine and n-(methyl)-thiazol-2-amine pour le traitement de maladies associés avec proteins amyloid ou similairs, comme p.e. alzheimer
US7902227B2 (en) 2007-07-27 2011-03-08 Janssen Pharmaceutica Nv. C-7 isoxazolinyl quinolone / naphthyridine derivatives useful as antibacterial agents
BRPI0919241B8 (pt) 2008-09-24 2021-05-25 Melinta Subsidiary Corp processo para fabricação de compostos de quinolona, e composição compreendendo composto de quinolona
EA025637B1 (ru) 2008-11-15 2017-01-30 Мелинта Терапьютикс, Инк. Противомикробные композиции
DE102009021535B8 (de) 2009-05-15 2012-12-13 Stabilo International Gmbh Verschlusskappe
EP2311823A1 (fr) 2009-10-15 2011-04-20 AC Immune S.A. Composés de 2,6-diaminopyridine appropriés pour le traitement de maladies liées à des protéines amyloïdes ou pour le traitement de maladies oculaires
CN102666490A (zh) * 2009-12-25 2012-09-12 宇部兴产株式会社 氨基吡啶化合物
CN103936717B (zh) * 2013-01-22 2016-08-10 上海医药工业研究院 一种delafloxacin中间体及其制备方法
CN103936718B (zh) * 2013-01-22 2016-06-29 上海医药工业研究院 一种高纯度delafloxacin的制备方法
WO2014152332A1 (fr) 2013-03-15 2014-09-25 Melinta Therapeutics, Inc. Procédés de traitement d'infections chez des patients atteints de surpoids et d'obésité utilisant d'antibiotiques
CN104098548B (zh) * 2013-04-11 2017-07-18 上海医药工业研究院 一种Delafloxacin的精制方法
TW201609652A (zh) * 2013-11-12 2016-03-16 陶氏農業科學公司 用於氟化化合物之過程（三）
CN104876911A (zh) * 2014-02-27 2015-09-02 南京工业大学 一种简易的方法合成德拉沙星
TWI732337B (zh) 2014-06-20 2021-07-01 美商梅琳塔有限責任公司 醫藥組成物及其用途
AU2015346023A1 (en) 2014-11-14 2017-06-01 Melinta Subsidiary Corp. Method for treating, preventing, or reducing the risk of skin infection
BR112018016842A2 (pt) * 2016-02-19 2018-12-26 Novartis Ag compostos de piridona tetracíclica como antivirais
CN108084161A (zh) * 2017-12-28 2018-05-29 北京沃邦医药科技有限公司 德拉沙星及其中间体的制备方法
CN108033948A (zh) * 2017-12-28 2018-05-15 北京沃邦医药科技有限公司 一种德拉沙星及其中间体的制备
CN114507230B (zh) * 2020-11-17 2023-07-21 西华大学 一种双环吡啶酮类衍生物、其合成方法及其用途
CN114539213A (zh) * 2021-08-18 2022-05-27 广东工业大学 一种氟喹诺酮类化合物及其制备方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3776917A (en) * 1972-06-05 1973-12-04 Schering Corp 2-amino-6-phenalkyl-aminopyridines and derivatives thereof
US3849429A (en) * 1973-03-30 1974-11-19 Olin Corp Halogenation of diaminopyridines in acidic media
US4994599A (en) * 1987-11-20 1991-02-19 Abbott Laboratories Intermediates for producing quinolone-3-carboxylic acids
JPS61152682A (ja) * 1984-12-27 1986-07-11 Dainippon Pharmaceut Co Ltd ピリドンカルボン酸誘導体、そのエステルおよびその塩
US5328908A (en) * 1988-10-24 1994-07-12 Procter & Gamble Pharmaceuticals, Inc. Antimicrobial quinolone thioureas
JPH03112919A (ja) * 1989-09-26 1991-05-14 Kao Corp 角質繊維染色剤組成物
JPH03112966A (ja) * 1989-09-26 1991-05-14 Koei Chem Co Ltd ３―アルキル―２，６―ジアミノピリジンの製造法
NO304832B1 (no) * 1992-05-27 1999-02-22 Ube Industries Aminokinolonderivater samt middel mot HIV
JP2993316B2 (ja) * 1992-05-27 1999-12-20 宇部興産株式会社 アリール基又は複素芳香環基置換アミノキノロン誘導体及びエイズ治療剤
AU679961B2 (en) * 1993-08-13 1997-07-17 Dong Wha Pharmaceutical Industrial Co., Ltd. Novel quinolone carboxylic acid derivatives
DE4425647A1 (de) * 1994-07-20 1996-01-25 Bayer Ag Heterocyclyl-1-phenyl substituierte Chinoloncarbonsäuren
DE4425659A1 (de) * 1994-07-20 1996-01-25 Bayer Ag Neue N1-diverse 6-Fluor-8-difluormethoxy substituierte Chinoloncarbonsäuren
MX9700871A (es) * 1994-08-02 1997-05-31 Procter & Gamble Procedimiento para hacer compuestos antimicrobianos.
JPH0848252A (ja) * 1994-08-04 1996-02-20 Otec Japan:Kk 荷 車
EP0787720B1 (fr) * 1994-10-20 2003-07-16 Wakunaga Seiyaku Kabushiki Kaisha Derive de pyridone-carboxylate, ou sel de celui-ci, et antibacterien le contenant comme principe actif
KR100499366B1 (ko) * 1995-01-30 2005-09-08 와쿠나가 세이야쿠 가부시키 가이샤 신규피리돈카르복실산유도체또는그염및그물질을유효성분으로하는항균제
NL1000360C2 (nl) * 1995-05-15 1996-11-18 Akzo Nobel Nv Werkwijze ter bereiding van pyridine-2, 6-diamines

Also Published As

Publication number Publication date
MX9802192A (es) 1998-09-30
EP0952151A2 (fr) 1999-10-27
EP0952151A3 (fr) 2001-08-01
CN1201459A (zh) 1998-12-09
CA2290709A1 (fr) 1997-03-27
AU7001696A (en) 1997-04-09
ES2169811T3 (es) 2002-07-16
HU225225B1 (en) 2006-08-28
CA2290712C (fr) 2003-09-09
EP0992501B1 (fr) 2002-08-28
HU9904390D0 (en) 2000-01-28
EP0992501A2 (fr) 2000-04-12
HK1016602A1 (en) 1999-11-05
US6156903A (en) 2000-12-05
DE69628466D1 (de) 2003-07-03
CN1136216C (zh) 2004-01-28
CN1105715C (zh) 2003-04-16
DE69628466T2 (de) 2004-04-01
HU225224B1 (en) 2006-08-28
ATE241601T1 (de) 2003-06-15
PT952151E (pt) 2003-10-31
KR100343331B1 (ko) 2002-07-15
CA2290712A1 (fr) 1997-03-27
ATE222906T1 (de) 2002-09-15
RU2167873C2 (ru) 2001-05-27
ATE210129T1 (de) 2001-12-15
JP3187795B2 (ja) 2001-07-11
CA2232728A1 (fr) 1997-03-27
PT992501E (pt) 2003-01-31
JP3103380B2 (ja) 2000-10-30
DE69617750T2 (de) 2002-08-08
EP0911327A1 (fr) 1999-04-28
RU2000113595A (ru) 2004-02-20
KR19990063671A (ko) 1999-07-26
BR9610485A (pt) 1999-07-27
DE69617750D1 (de) 2002-01-17
DK0911327T3 (da) 2002-04-02
CN1258674A (zh) 2000-07-05
ES2183473T3 (es) 2003-03-16
CN1258672A (zh) 2000-07-05
JPH11322715A (ja) 1999-11-24
AU707565B2 (en) 1999-07-15
JP2000136191A (ja) 2000-05-16
DE69623358D1 (de) 2002-10-02
DK0992501T3 (da) 2002-10-28
EP0952151B1 (fr) 2003-05-28
HUP9902714A2 (hu) 1999-12-28
JP3304311B2 (ja) 2002-07-22
WO1997011068A1 (fr) 1997-03-27
PT911327E (pt) 2002-05-31
KR100299430B1 (ko) 2001-09-06
RU2177945C1 (ru) 2002-01-10
EP0911327B1 (fr) 2001-12-05
EP0992501A3 (fr) 2001-09-05
RU2171252C2 (ru) 2001-07-27
BR9610485B8 (pt) 2014-08-05
CN1196683C (zh) 2005-04-13
AU721805B2 (en) 2000-07-13
EP0911327A4 (fr) 1999-04-28
BR9610485B1 (pt) 2010-08-10
CA2232728C (fr) 2003-11-04
DE69623358T2 (de) 2003-05-08
ES2200439T3 (es) 2004-03-01
HUP9902714A3 (en) 2002-03-28
HUP9904389A3 (en) 2002-03-28
BR9612862B8 (pt) 2014-08-05
HU9904389D0 (en) 2000-01-28
HUP9904390A3 (en) 2002-03-28
CA2290709C (fr) 2003-11-04
US5998436A (en) 1999-12-07
AU3122799A (en) 1999-08-12
HK1028032A1 (en) 2001-02-02
US6133284A (en) 2000-10-17

Similar Documents

Publication Publication Date Title
DK0952151T3 (da) Mellemprodukter til anvendelse ved fremstilling af nye pyridoncarboxylsyrederivater eller deres salte
DE69729583D1 (de) N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3-on derivative als faktor xa inhibitoren
PT96937A (pt) Processo para a preparacao de derivados de n-(4-piperidinil) (di-hidro-benzofurano ou di-hidro-2h-benzopiran) carboxamida e de composicoes farmaceuticas que os contem
AR018169A1 (es) Uso de compuestos derivados trisustituidos de 1,3,5-triazina para la elaboracion de un medicamento, compuestos derivados de los mismos, un procesopara su preparacion, una composicion farmaceutica que los comprende, un proceso para su preparacion, la combinacion de los mismos con un compuesto antiret
ATE281430T1 (de) Anilin-derivate als stickstoffmonoxid synthase- inhibitoren
NZ328854A (en) Substituted di-amino 1,3,5-triazine derivatives useful for treating HIV infections
NO331165B1 (no) Derivater av dioksan-2-alkylkarbamater, fremgangsmate for fremstilling derav og anvendelse av de samme for fremstilling av medikamenter
NO308248B1 (no) Forbindelser som er anvendbare som antiproliferative midler og GARFT-inhibitorer, samt farmasøytisk preparat
DE69818041D1 (de) Cyanoguanidine als zellproliferation inhibitoren
DE68925933D1 (de) Arylalkylamine und -amide mit krampflösender und nervenschützender Wirkung
DE69817810D1 (de) Cyanoguanidine als zellproliferation inhibitoren
TR200103019T2 (tr) Yeni 8A-ve 9A-15-elemanlı laktamlar
NO904135L (no) Fremgangsmaate for fremstilling av nye substituerte alkylpiperidiner og deres anvendelse som inhibitorer av kolesterolsyntese.
BR0312477A (pt) Composição de tratamento capilar, usos de composição e método de tratamento de cabelos
DE60111768D1 (de) N-formyl hydroxylamine derivate als inhibitoren der bakteriellen polypeptid deformylase zur behandlung von mikrobiellen infektionen